InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: TomP1 post# 33207

Monday, 10/05/2015 6:43:59 AM

Monday, October 05, 2015 6:43:59 AM

Post# of 48316
Actually no, as Dr.Pierce with considerable direct Keytruda experience as the former MRK principal investigator was the source of the info that PD simply stated publicly. If anyone was in the best position to come to Q1 decision it was Dr. Pierce. The FDA simply decided to delay and research more the proposed Combo.

Pivotal P2Bs in the Cancer sector are badly needed and come after considerable years of many deaths using the Chemo, Radiation, Surgery therapies that are essentially failure to arrest Cancers for most persons. Personally I have lost family members and friends to such therapies.

Immunotherapies are making advances now only in the last 12 months thru the approvals of BMS and MRK new drugs. In $ONCS Combo case the FDA simply wanted more time and info before allowing the trial to go forth.

$ONCS 41 person Combo trial is now in full operation.

https://clinicaltrials.gov/ct2/show/NCT02493361?term=UCSF+and+keytruda&rank=2

What is amazing is that the UCSF has taken on full sponsorship of this expected $2 to 3 millions cost over the 2 years projected duration.